Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

pCLPG: a p53-driven retroviral system.

Bryan E Strauss1, Eugenia Costanzi-Strauss

  • 1Heart Institute, InCor, University of São Paulo School of Medicine, São Paulo, Brazil. bstrauss@usp.br

Virology
|March 31, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenovirus mediated gene therapy in cell lines derived from canine oral melanoma.

Frontiers in immunology·2026
Same author

Non-replicating adenoviral vectors for cancer gene therapy.

Advances in cancer research·2026
Same author

Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges.

Nanomedicine (London, England)·2025
Same author

Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade.

Molecular therapy. Oncology·2025
Same author

Editorial: Interferons: key modulators of the immune system in cancer.

Frontiers in immunology·2023
Same author

Induction of Immune-Stimulating Factors and Oncolysis Upon p14<sup>ARF</sup> Gene Transfer in Melanoma Cell Lines.

DNA and cell biology·2022

Researchers modified a retroviral system to create pCLPG, a tool for tracking p53 activity. This new system enhances gene expression driven by p53, offering a valuable method for gene transfer and studying p53 function.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • The pCL retroviral system is a tool for gene delivery.
  • The p53 protein is a critical tumor suppressor involved in cellular responses to DNA damage.
  • Developing sensitive reporter systems for p53 activity is essential for cancer research.

Purpose of the Study:

  • To engineer a modified pCL retroviral system (pCLPG) incorporating a p53-responsive element.
  • To evaluate the pCLPG system's ability to report on p53 transcriptional activity.
  • To assess the utility of pCLPG as a gene transfer vehicle driven by p53.

Main Methods:

  • Modification of the pCL retroviral system by inserting a p53-responsive element (PG) into the 3'-LTR U3 region.
  • Transduction of cells with the modified pCLPG system.

Related Experiment Videos

  • Induction of endogenous p53 using genotoxic agents.
  • Comparison of pCLPG expression with the parental virus under varying promoter conditions.

    • Main Results:

    • The pCLPG system successfully drives expression in transduced cells using either endogenous or exogenous wild-type p53.
    • Genotoxic induction of p53 led to significantly higher pCLPG expression compared to the parental virus.
    • Maximal expression was observed when the native promoter was replaced by the p53-responsive element.

    Conclusions:

    • The novel pCLPG retroviral system effectively reports on p53 function.
    • pCLPG demonstrates potential as a gene transfer vehicle for in vitro and in vivo applications.
    • This modified system offers an improved tool for studying p53-mediated gene expression.